A549-LUC

A549 Luciferase Cell Line engineered for stable, high-efficiency expression of the luciferase gene.This advanced tool delivers exceptionally high imaging quality and precise, quantifiable luminescence, ensuring your data is both robust and publication-ready.
Designed for versatility, the A549 Luciferase Cell Line seamlessly adapts to a broad spectrum of applications—from promoter activity assays and mammalian two-hybrid studies to sophisticated in vivo imaging.
A549 cell line was established by D. J. Griad through the transplantation and culture of lung cancer tissue, originating from a 58-year-old Caucasian male. A549 cells are capable of synthesizing lecithin containing high levels of unsaturated fatty acids via the cytidine diphosphate choline pathway.